-
1
-
-
0033809968
-
Peptide analogs in the therapy of prostate cancer
-
Schally AV, Comaru-Schally AM, Plonowski A, Nagy A, Halmos G, Rekasi Z. Peptide analogs in the therapy of prostate cancer. Prostate 2000;45:158-166.
-
(2000)
Prostate
, vol.45
, pp. 158-166
-
-
Schally, A.V.1
Comaru-Schally, A.M.2
Plonowski, A.3
Nagy, A.4
Halmos, G.5
Rekasi, Z.6
-
2
-
-
0033849284
-
The LHRH antagonist Cetrorelix: A review
-
Reissmann T, Schally AV, Bouchard P, Riethmüller H, Engel J. The LHRH antagonist Cetrorelix: A review. Hum Reprod Update 2000;6:322-331.
-
(2000)
Hum Reprod Update
, vol.6
, pp. 322-331
-
-
Reissmann, T.1
Schally, A.V.2
Bouchard, P.3
Riethmüller, H.4
Engel, J.5
-
3
-
-
33846412644
-
Hypothalamic and other peptide hormones
-
Holland JF, Frei E III, Bast RC, Jr, editors, 7th edition. Hamilton, Ontario, BC: Decker
-
Schally AV, Comaru-Schally AM. Hypothalamic and other peptide hormones. In: Holland JF, Frei E III, Bast RC, Jr., editors. Cancer medicine. 7th edition. Hamilton, Ontario, BC: Decker 2006. 802-816.
-
(2006)
Cancer medicine
, pp. 802-816
-
-
Schally, A.V.1
Comaru-Schally, A.M.2
-
4
-
-
0026692109
-
Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice
-
Redding TW, Schally AV, Radulovic S, Milovanovic S, Szepeshazi K, Isaacs JT. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice. Cancer Res 1992;52: 2538-2544.
-
(1992)
Cancer Res
, vol.52
, pp. 2538-2544
-
-
Redding, T.W.1
Schally, A.V.2
Radulovic, S.3
Milovanovic, S.4
Szepeshazi, K.5
Isaacs, J.T.6
-
5
-
-
0032538353
-
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors
-
Lamharzi N, Schally AV, Koppan M. Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors. Regul Pept 1998;77: 185-192.
-
(1998)
Regul Pept
, vol.77
, pp. 185-192
-
-
Lamharzi, N.1
Schally, A.V.2
Koppan, M.3
-
6
-
-
0031876636
-
-
Lamharzi N, Halmos G, Jungwirth A, Schally AV. Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist Cetrorelix in DU-145 prostate tumor xenografts in nude mice. Int J Oncol 1998;13:429-435.
-
Lamharzi N, Halmos G, Jungwirth A, Schally AV. Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist Cetrorelix in DU-145 prostate tumor xenografts in nude mice. Int J Oncol 1998;13:429-435.
-
-
-
-
7
-
-
0030814022
-
Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
-
Jungwirth A, Pinski J, Galvan G, Halmos G, Szepeshazi K, Cai RZ, Groot K, Vadillo-Buenfil M, Schally AV. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. Eur J Cancer 1997;33:1141-1148.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1141-1148
-
-
Jungwirth, A.1
Pinski, J.2
Galvan, G.3
Halmos, G.4
Szepeshazi, K.5
Cai, R.Z.6
Groot, K.7
Vadillo-Buenfil, M.8
Schally, A.V.9
-
8
-
-
0030751523
-
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
-
Jungwirth A, Galvan G, Pinski J, Halmos G, Szepeshazi K, Cai RZ, Groot K, Schally AV. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate 1997;32:164-172.
-
(1997)
Prostate
, vol.32
, pp. 164-172
-
-
Jungwirth, A.1
Galvan, G.2
Pinski, J.3
Halmos, G.4
Szepeshazi, K.5
Cai, R.Z.6
Groot, K.7
Schally, A.V.8
-
9
-
-
0035834049
-
Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist Triptorelin on the gene expression of pituitary LHRH receptors in rats
-
Kovacs M, Schally AV. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist Triptorelin on the gene expression of pituitary LHRH receptors in rats. Proc Natl Acad Sci USA 2001;98:12197-12202.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 12197-12202
-
-
Kovacs, M.1
Schally, A.V.2
-
11
-
-
0032739426
-
Luteinizing hormone-releasing hormone analogs: Their impact on the control of tumorigenesis
-
Schally AV. Luteinizing hormone-releasing hormone analogs: Their impact on the control of tumorigenesis. Peptides 1999;20:1247-1262.
-
(1999)
Peptides
, vol.20
, pp. 1247-1262
-
-
Schally, A.V.1
-
12
-
-
0032052309
-
Effects of LHRH-analogues on mitogenic signal transduction in cancer cells
-
Emons G, Muller V, Ortmann O, Schulz KD. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. J Steroid Biochem Mol Biol 1998;65(1-6):199-206.
-
(1998)
J Steroid Biochem Mol Biol
, vol.65
, Issue.1-6
, pp. 199-206
-
-
Emons, G.1
Muller, V.2
Ortmann, O.3
Schulz, K.D.4
-
13
-
-
0034242518
-
Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix
-
Halmos G, Schally AV, Kahan Z. Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix. Int J Oncol 2000;17:367-373.
-
(2000)
Int J Oncol
, vol.17
, pp. 367-373
-
-
Halmos, G.1
Schally, A.V.2
Kahan, Z.3
-
14
-
-
0028281076
-
Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer
-
Gonzalez-Barcena D, Vadillo-Buenfil M, Gomez-Orta F, Fuentes Garcia M, Cardenas-Cornejo I, Graef-Sanchez A, Comaru-Schally AM, Schally AV. Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer. Prostate 1994;24: 84-92.
-
(1994)
Prostate
, vol.24
, pp. 84-92
-
-
Gonzalez-Barcena, D.1
Vadillo-Buenfil, M.2
Gomez-Orta, F.3
Fuentes Garcia, M.4
Cardenas-Cornejo, I.5
Graef-Sanchez, A.6
Comaru-Schally, A.M.7
Schally, A.V.8
-
15
-
-
0029240272
-
Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord
-
Gonzalez-Barcena D, Vadillo-Buenfil M, Cortez-Morales A, Fuentes-Garcia M, Cardenas-Cornejo I, Comaru-Schally AM, Schally AV. Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord. Urology 1995;45:275-281.
-
(1995)
Urology
, vol.45
, pp. 275-281
-
-
Gonzalez-Barcena, D.1
Vadillo-Buenfil, M.2
Cortez-Morales, A.3
Fuentes-Garcia, M.4
Cardenas-Cornejo, I.5
Comaru-Schally, A.M.6
Schally, A.V.7
-
16
-
-
0033485288
-
Antagonistic analogs of growth hormone-releasing hormone: New potential antitumor agents
-
Schally AV, Varga JL. Antagonistic analogs of growth hormone-releasing hormone: New potential antitumor agents. Trends Endocrinol Metab 1999;10:383-391.
-
(1999)
Trends Endocrinol Metab
, vol.10
, pp. 383-391
-
-
Schally, A.V.1
Varga, J.L.2
-
17
-
-
0033955413
-
Deregulated expression of growth factors and their receptors in the development of prostate cancer
-
Djakiew D. Deregulated expression of growth factors and their receptors in the development of prostate cancer. Prostate 2000;42:150-160.
-
(2000)
Prostate
, vol.42
, pp. 150-160
-
-
Djakiew, D.1
-
18
-
-
0037092971
-
Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease
-
Hellawell GO, Turner GD, Davies DR, Poulsom R, Brewster SF, Macaulay VM. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res 2002;62: 2942-2950.
-
(2002)
Cancer Res
, vol.62
, pp. 2942-2950
-
-
Hellawell, G.O.1
Turner, G.D.2
Davies, D.R.3
Poulsom, R.4
Brewster, S.F.5
Macaulay, V.M.6
-
19
-
-
0028113415
-
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
-
Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994;54:5474-5478.
-
(1994)
Cancer Res
, vol.54
, pp. 5474-5478
-
-
Culig, Z.1
Hobisch, A.2
Cronauer, M.V.3
Radmayr, C.4
Trapman, J.5
Hittmair, A.6
Bartsch, G.7
Klocker, H.8
-
20
-
-
0033986891
-
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines
-
Jongsma J, Oomen MHA, Noordzij MA, Van Weerden WM, Martens GJ, van der Kwast TH, Schroder FH, van Steenbrugge GJ. Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines. Prostate 2000;42:34-44.
-
(2000)
Prostate
, vol.42
, pp. 34-44
-
-
Jongsma, J.1
Oomen, M.H.A.2
Noordzij, M.A.3
Van Weerden, W.M.4
Martens, G.J.5
van der Kwast, T.H.6
Schroder, F.H.7
van Steenbrugge, G.J.8
-
21
-
-
0038758829
-
New advances on prostate carcinogenesis and therapies: Involvement of EGF-EGF-R transduction system
-
Mimeault M, Pommery N, Henichart JP. New advances on prostate carcinogenesis and therapies: Involvement of EGF-EGF-R transduction system. Growth Factors 2003;21:1-14.
-
(2003)
Growth Factors
, vol.21
, pp. 1-14
-
-
Mimeault, M.1
Pommery, N.2
Henichart, J.P.3
-
22
-
-
0035496220
-
The development of androgen-independent prostate cancer
-
Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1:34-45.
-
(2001)
Nat Rev Cancer
, vol.1
, pp. 34-45
-
-
Feldman, B.J.1
Feldman, D.2
-
23
-
-
0034234650
-
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways
-
Plonowski A, Schally AV, Varga JL, Rekasi Z, Hebert F, Halmos G, Groot K. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways. Prostate 2000;44:172-180.
-
(2000)
Prostate
, vol.44
, pp. 172-180
-
-
Plonowski, A.1
Schally, A.V.2
Varga, J.L.3
Rekasi, Z.4
Hebert, F.5
Halmos, G.6
Groot, K.7
-
24
-
-
0036680275
-
Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: Lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor
-
Plonowski A, Schally AV, Letsch M, Krupa M, Hebert F, Busto R, Groot K, Varga JL. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: Lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor. Prostate 2002;52(3):173-182.
-
(2002)
Prostate
, vol.52
, Issue.3
, pp. 173-182
-
-
Plonowski, A.1
Schally, A.V.2
Letsch, M.3
Krupa, M.4
Hebert, F.5
Busto, R.6
Groot, K.7
Varga, J.L.8
-
25
-
-
0037417815
-
Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers
-
Letsch M, Schally AV, Busto R, Bajo AM, Varga JL. Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers. Proc Natl Acad Sci USA 2003;100:1250-1255.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 1250-1255
-
-
Letsch, M.1
Schally, A.V.2
Busto, R.3
Bajo, A.M.4
Varga, J.L.5
-
26
-
-
22144492242
-
Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers
-
Stangelberger A, Schally AV, Varga JL, Hammann BD, Groot K, Halmos G, Cai RZ, Zarandi M. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers. Prostate 2005;64:303-315.
-
(2005)
Prostate
, vol.64
, pp. 303-315
-
-
Stangelberger, A.1
Schally, A.V.2
Varga, J.L.3
Hammann, B.D.4
Groot, K.5
Halmos, G.6
Cai, R.Z.7
Zarandi, M.8
-
27
-
-
0034641750
-
Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers
-
Rekasi Z, Czompoly T, Schally AV, Halmos G. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc Natl Acad Sci USA 2000;97:10561-10566.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 10561-10566
-
-
Rekasi, Z.1
Czompoly, T.2
Schally, A.V.3
Halmos, G.4
-
28
-
-
0037039396
-
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs
-
Kiaris H, Schally AV, Busto R, Halmos G, Artavanis-Tsakonas S, Varga JL. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. Proc Natl Acad Sci USA 2002;99:196-200.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 196-200
-
-
Kiaris, H.1
Schally, A.V.2
Busto, R.3
Halmos, G.4
Artavanis-Tsakonas, S.5
Varga, J.L.6
-
29
-
-
0034797098
-
A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines
-
Chopin LK, Herington AC. A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines. Prostate 2001;49:116-121.
-
(2001)
Prostate
, vol.49
, pp. 116-121
-
-
Chopin, L.K.1
Herington, A.C.2
-
30
-
-
0036776259
-
Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer
-
Halmos G, Schally AV, Czompoly T, Krupa M, Varga JL, Rekasi Z. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer. J Clin Endocrinol Metab 2002;87:4707-4714.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4707-4714
-
-
Halmos, G.1
Schally, A.V.2
Czompoly, T.3
Krupa, M.4
Varga, J.L.5
Rekasi, Z.6
-
31
-
-
0032555287
-
Growth hormone-releasing hormone antagonist MZ-5-156inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors
-
Lamharzi N, Schally AV, Koppan M, Groot K. Growth hormone-releasing hormone antagonist MZ-5-156inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors. Proc Natl Acad Sci USA 1998;95:8864-8868.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 8864-8868
-
-
Lamharzi, N.1
Schally, A.V.2
Koppan, M.3
Groot, K.4
-
32
-
-
1642473188
-
Antagonists of growth hormone-releasing hormone (GH-RH) enhance tumor growth inhibition induced by androgen deprivation in human MDA-Pca-2b prostate cancers
-
Letsch M, Schally AV, Stangelberger A, Groot K, Varga JL. Antagonists of growth hormone-releasing hormone (GH-RH) enhance tumor growth inhibition induced by androgen deprivation in human MDA-Pca-2b prostate cancers. Eur J Cancer 2004;40:436-444.
-
(2004)
Eur J Cancer
, vol.40
, pp. 436-444
-
-
Letsch, M.1
Schally, A.V.2
Stangelberger, A.3
Groot, K.4
Varga, J.L.5
-
33
-
-
0038475987
-
LuCap 35: A new model of prostate cancer progression to androgen independence
-
Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL. LuCap 35: A new model of prostate cancer progression to androgen independence. Prostate 2003;55:239-246.
-
(2003)
Prostate
, vol.55
, pp. 239-246
-
-
Corey, E.1
Quinn, J.E.2
Buhler, K.R.3
Nelson, P.S.4
Macoska, J.A.5
True, L.D.6
Vessella, R.L.7
-
34
-
-
0024271361
-
New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues
-
Bajusz S, Csernus VJ, Janaky T, Bokser L, Fekete M, Schally AV. New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues. Int J Pept Protein Res 1988;32:425-435.
-
(1988)
Int J Pept Protein Res
, vol.32
, pp. 425-435
-
-
Bajusz, S.1
Csernus, V.J.2
Janaky, T.3
Bokser, L.4
Fekete, M.5
Schally, A.V.6
-
35
-
-
1242342212
-
Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10
-
Varga JL, Schally AV, Horvath JE, Kovacs M, Halmos G, Groot K, Toller GL, Rekasi Z, Zarandi M. Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10. Proc Natl Acad Sci USA 2004;101:1708-1713.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 1708-1713
-
-
Varga, J.L.1
Schally, A.V.2
Horvath, J.E.3
Kovacs, M.4
Halmos, G.5
Groot, K.6
Toller, G.L.7
Rekasi, Z.8
Zarandi, M.9
-
36
-
-
33645851038
-
Antagonists of growth hormone-releasing hormone in oncology
-
Schally AV, Varga JL. Antagonists of growth hormone-releasing hormone in oncology. Comb Chem High Throughput Screen. 2006;9:163-170.
-
(2006)
Comb Chem High Throughput Screen
, vol.9
, pp. 163-170
-
-
Schally, A.V.1
Varga, J.L.2
-
37
-
-
0037039710
-
Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207
-
Plonowski A, Schally AV, Nagy A, Groot K, Krupa M, Navone NM, Logothetis C. Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207. Cancer Lett 2002;176:57-63.
-
(2002)
Cancer Lett
, vol.176
, pp. 57-63
-
-
Plonowski, A.1
Schally, A.V.2
Nagy, A.3
Groot, K.4
Krupa, M.5
Navone, N.M.6
Logothetis, C.7
-
38
-
-
28444478741
-
The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues
-
Havt A, Schally AV, Halmos G, Varga JL, Toller GL, Horvath JE, Szepeshazi K, Koster F, Kovitz K, Groot K, Zarandi M, Kanashiro CA. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci USA 2005;102: 17424-17429.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 17424-17429
-
-
Havt, A.1
Schally, A.V.2
Halmos, G.3
Varga, J.L.4
Toller, G.L.5
Horvath, J.E.6
Szepeshazi, K.7
Koster, F.8
Kovitz, K.9
Groot, K.10
Zarandi, M.11
Kanashiro, C.A.12
-
39
-
-
0034641699
-
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone
-
Halmos G, Schally AV, Varga JL, Plonowski A, Rekasi Z, Czompoli T. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. Proc Natl Acad Sci USA 2000;97:10555-10560.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 10555-10560
-
-
Halmos, G.1
Schally, A.V.2
Varga, J.L.3
Plonowski, A.4
Rekasi, Z.5
Czompoli, T.6
-
40
-
-
0031016389
-
Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095
-
Halmos G, Schally AV. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Proc Natl Acad Sci USA 1997;94:956-960.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 956-960
-
-
Halmos, G.1
Schally, A.V.2
-
41
-
-
0033963203
-
High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers
-
Halmos G, Arencibia JM, Schally AV, Davis R, Bostwick DG. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers. J Urol 2000;163:623-629.
-
(2000)
J Urol
, vol.163
, pp. 623-629
-
-
Halmos, G.1
Arencibia, J.M.2
Schally, A.V.3
Davis, R.4
Bostwick, D.G.5
-
42
-
-
0030979558
-
Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone
-
Jungwirth A, Schally AV, Pinski J, Halmos G, Groot K, Armatis P, Vadillo-Buenfil M. Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone. Br J Cancer 1997;75:1585-1592.
-
(1997)
Br J Cancer
, vol.75
, pp. 1585-1592
-
-
Jungwirth, A.1
Schally, A.V.2
Pinski, J.3
Halmos, G.4
Groot, K.5
Armatis, P.6
Vadillo-Buenfil, M.7
-
43
-
-
0029072101
-
Distant metastases from prostatic carcinoma express androgen receptor protein
-
Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A. Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res 1995;55:3068-3072.
-
(1995)
Cancer Res
, vol.55
, pp. 3068-3072
-
-
Hobisch, A.1
Culig, Z.2
Radmayr, C.3
Bartsch, G.4
Klocker, H.5
Hittmair, A.6
-
44
-
-
0035996854
-
Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers
-
Plonowski A, Schally AV, Busto R, Krupa M, Varga JL, Halmos G. Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers. Peptides 2002;23:1127-1133.
-
(2002)
Peptides
, vol.23
, pp. 1127-1133
-
-
Plonowski, A.1
Schally, A.V.2
Busto, R.3
Krupa, M.4
Varga, J.L.5
Halmos, G.6
-
45
-
-
0034898083
-
Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide
-
Rekasi Z, Schally AV, Plonowski A, Czompoly T, Csernus B, Varga JL. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide. Prostate 2001;48:188-199.
-
(2001)
Prostate
, vol.48
, pp. 188-199
-
-
Rekasi, Z.1
Schally, A.V.2
Plonowski, A.3
Czompoly, T.4
Csernus, B.5
Varga, J.L.6
-
46
-
-
0034455291
-
Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: Evidence from in vitro studies on human prostatic and pancreatic cancers
-
Rekasi Z, Varga JL, Schally AV, Halmos G, Armatis P, Groot K, Czompoly T. Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: Evidence from in vitro studies on human prostatic and pancreatic cancers. Endocrinology 2000; 141:2120-2128.
-
(2000)
Endocrinology
, vol.141
, pp. 2120-2128
-
-
Rekasi, Z.1
Varga, J.L.2
Schally, A.V.3
Halmos, G.4
Armatis, P.5
Groot, K.6
Czompoly, T.7
-
47
-
-
0035182258
-
-
Schally AV, Halmos G, Rekasi Z, Arencibia JM. The actions of luteinizing hormone releasing hormone agonists, antagonists, and cytotoxic analogs on the luteinizing hormone releasing hormone receptors on the pituitary and tumors. Devroey P., ed. 12; Saunders, Philadelphia: Infertility and Reproductive Medicine Clinics of North America: GnRH Analogue; 2001; pp 17-44.
-
Schally AV, Halmos G, Rekasi Z, Arencibia JM. The actions of luteinizing hormone releasing hormone agonists, antagonists, and cytotoxic analogs on the luteinizing hormone releasing hormone receptors on the pituitary and tumors. Devroey P., ed. Vol. 12; Saunders, Philadelphia: Infertility and Reproductive Medicine Clinics of North America: GnRH Analogue; 2001; pp 17-44.
-
-
-
-
48
-
-
0032584108
-
Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells
-
Okada F, Rak JW, Croix BS, Lieubeau B, Kaya M, Roncari L, Shirasawa S, Sasazuki T, Kerbel RS. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci USA 1998;95: 3609-3614.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 3609-3614
-
-
Okada, F.1
Rak, J.W.2
Croix, B.S.3
Lieubeau, B.4
Kaya, M.5
Roncari, L.6
Shirasawa, S.7
Sasazuki, T.8
Kerbel, R.S.9
-
49
-
-
15144350201
-
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I
-
Punglia RS, Lu M, Hsu J, Kuroki M, Tolentino MJ, Keough K, Levy AP, Levy NS, Goldberg MA, D'Amato RJ, Adamis AP. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 1997;46:1619-1626.
-
(1997)
Diabetes
, vol.46
, pp. 1619-1626
-
-
Punglia, R.S.1
Lu, M.2
Hsu, J.3
Kuroki, M.4
Tolentino, M.J.5
Keough, K.6
Levy, A.P.7
Levy, N.S.8
Goldberg, M.A.9
D'Amato, R.J.10
Adamis, A.P.11
-
50
-
-
0028910567
-
Consequences of angiogenesis for tumor progression, metastasis and cancer therapy
-
Rak JW, St. Croix BD, Kerbel RS. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 1995;6:3-18.
-
(1995)
Anticancer Drugs
, vol.6
, pp. 3-18
-
-
Rak, J.W.1
St. Croix, B.D.2
Kerbel, R.S.3
-
51
-
-
0030500444
-
Vascular endothelial growth factor
-
Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996; 32a:2413-2422.
-
(1996)
Eur J Cancer
, vol.32 a
, pp. 2413-2422
-
-
Ferrara, N.1
-
52
-
-
0037453207
-
GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells
-
Siejka A, Lawnicka H, Komorowski J, Schally AV, Stepien T, Krupinski R, Stepien H. GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells. Life Sci 2003;72:2473-2479.
-
(2003)
Life Sci
, vol.72
, pp. 2473-2479
-
-
Siejka, A.1
Lawnicka, H.2
Komorowski, J.3
Schally, A.V.4
Stepien, T.5
Krupinski, R.6
Stepien, H.7
-
53
-
-
0032821184
-
Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs
-
Szepeshazi K, Halmos G, Schally AV, Arencibia JM, Groot K, Vadillo-Buenfil M, Rodriguez-Martin E. Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs. J Cancer Res Clin Oncol 1999;125:444-452.
-
(1999)
J Cancer Res Clin Oncol
, vol.125
, pp. 444-452
-
-
Szepeshazi, K.1
Halmos, G.2
Schally, A.V.3
Arencibia, J.M.4
Groot, K.5
Vadillo-Buenfil, M.6
Rodriguez-Martin, E.7
-
54
-
-
27744575622
-
Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of Bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signaling
-
Stangelberger A, Schally AV, Varga JL, Zarandi M, Cai RZ, Baker B, Hammann BD, Armatis P, Kanashiro CA. Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of Bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signaling. Eur J Cancer 2005;41:2735-2744.
-
(2005)
Eur J Cancer
, vol.41
, pp. 2735-2744
-
-
Stangelberger, A.1
Schally, A.V.2
Varga, J.L.3
Zarandi, M.4
Cai, R.Z.5
Baker, B.6
Hammann, B.D.7
Armatis, P.8
Kanashiro, C.A.9
-
55
-
-
0022489875
-
Early events elicited by Bombesin and structurally related peptides in quiescent Swiss 3TC cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding
-
Zachary I, Sinnett-Smith JW, Rozengurt E. Early events elicited by Bombesin and structurally related peptides in quiescent Swiss 3TC cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol 1986;102:2211-2222.
-
(1986)
J Cell Biol
, vol.102
, pp. 2211-2222
-
-
Zachary, I.1
Sinnett-Smith, J.W.2
Rozengurt, E.3
-
56
-
-
0026071869
-
-
Lee MT, Liebow C, Kamer AR, Schally AV. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosinase residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA 1991;88:1656-1660.
-
Lee MT, Liebow C, Kamer AR, Schally AV. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosinase residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA 1991;88:1656-1660.
-
-
-
|